Press Releases & Statements

Investor Relations

Month Year

Month Year

New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
- RSV
Aug 12, 2019
Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting
- RSV
Aug 8, 2019
Novavax Provides Updates on the Global Pathways to Licensure for ResVax™
- RSV
Jun 10, 2019
Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases
- RSV
May 1, 2019
Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress
- RSV
Apr 9, 2019
Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
- RSV
Feb 28, 2019
Novavax to Highlight RSV Program Data at Two Upcoming Meetings
- RSV
Oct 2, 2018
Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine
- RSV
May 7, 2018
Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine
- RSV
Dec 18, 2017
Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
- RSV
Jul 24, 2017

Show per page